TrueWealth Advisors LLC Purchases Shares of 367 Chemed Co. (NYSE:CHE)

TrueWealth Advisors LLC acquired a new position in shares of Chemed Co. (NYSE:CHE) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 367 shares of the company’s stock, valued at approximately $226,000.

Other hedge funds have also recently bought and sold shares of the company. Whipplewood Advisors LLC raised its stake in Chemed by 54.5% in the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company’s stock valued at $31,000 after acquiring an additional 18 shares during the period. CIBC Asset Management Inc boosted its stake in Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock worth $242,000 after buying an additional 22 shares in the last quarter. CBIZ Investment Advisory Services LLC boosted its stake in Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after buying an additional 22 shares in the last quarter. CIBC Private Wealth Group LLC boosted its stake in Chemed by 13.5% in the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company’s stock worth $98,000 after buying an additional 22 shares in the last quarter. Finally, Independent Advisor Alliance boosted its stake in Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock worth $1,207,000 after buying an additional 25 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of analyst reports. Royal Bank of Canada increased their price objective on Chemed from $667.00 to $674.00 and gave the company an “outperform” rating in a research note on Monday, April 28th. Wall Street Zen raised Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th.

Chemed Trading Down 1.3%

Shares of Chemed stock opened at $560.96 on Thursday. The firm has a market capitalization of $8.21 billion, a P/E ratio of 28.35, a P/E/G ratio of 2.15 and a beta of 0.59. The business has a fifty day simple moving average of $578.07 and a two-hundred day simple moving average of $565.95. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $623.61.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.20 earnings per share. Analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.36%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed’s dividend payout ratio (DPR) is 9.74%.

Insider Buying and Selling at Chemed

In other news, EVP Spencer S. Lee sold 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total transaction of $866,790.00. Following the sale, the executive vice president now directly owns 16,127 shares of the company’s stock, valued at $9,319,148.22. This represents a 8.51% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares in the company, valued at $62,566,139.07. The trade was a 0.97% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,500 shares of company stock worth $3,213,780 in the last three months. 3.29% of the stock is currently owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.